Your browser doesn't support javascript.
loading
N6 -methyladenosine-modified circSTX6 promotes hepatocellular carcinoma progression by regulating the HNRNPD/ATF3 axis and encoding a 144 amino acid polypeptide.
Lu, Jiahua; Ru, Junnan; Chen, Yunhao; Ling, Zhenan; Liu, Hanqing; Ding, Bo; Jiang, Yifan; Ma, Jun; Zhang, Deguo; Ge, Jiangzhen; Li, Yu; Sun, Fei; Chen, Diyu; Zheng, Shusen; Wu, Jian.
Afiliação
  • Lu J; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Peoples Republic of China.
  • Ru J; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, Peoples Republic of China.
  • Chen Y; Key Laboratory of the diagnosis and treatment of organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment For Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), Hangzhou, Peoples Republic of China.
  • Ling Z; Key Laboratory of Organ Transplantation, Research Center for Diagnosis and Treatment of Hepatobiliary Diseases, Hangzhou, Zhejiang Province, Peoples Republic of China.
  • Liu H; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Peoples Republic of China.
  • Ding B; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, Peoples Republic of China.
  • Jiang Y; Key Laboratory of the diagnosis and treatment of organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment For Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), Hangzhou, Peoples Republic of China.
  • Ma J; Key Laboratory of Organ Transplantation, Research Center for Diagnosis and Treatment of Hepatobiliary Diseases, Hangzhou, Zhejiang Province, Peoples Republic of China.
  • Zhang D; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Peoples Republic of China.
  • Ge J; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, Peoples Republic of China.
  • Li Y; Key Laboratory of the diagnosis and treatment of organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment For Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), Hangzhou, Peoples Republic of China.
  • Sun F; Key Laboratory of Organ Transplantation, Research Center for Diagnosis and Treatment of Hepatobiliary Diseases, Hangzhou, Zhejiang Province, Peoples Republic of China.
  • Chen D; Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Peoples Republic of China.
  • Zheng S; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Peoples Republic of China.
  • Wu J; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, Peoples Republic of China.
Clin Transl Med ; 13(10): e1451, 2023 10.
Article em En | MEDLINE | ID: mdl-37877357
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Ribonucleoproteínas Nucleares Heterogêneas Grupo D / MicroRNAs / Fator 3 Ativador da Transcrição / RNA Circular / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Ribonucleoproteínas Nucleares Heterogêneas Grupo D / MicroRNAs / Fator 3 Ativador da Transcrição / RNA Circular / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article